MEI CHING LEE: Open Payments
NPI 1205512977 · ELDERSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 29 payments from 11 companies in 2025. Trend: 2023 $164 · 2024 $424 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $121 |
| Amgen Inc. | 6 | $117 |
| PFIZER INC. | 4 | $70 |
| Novo Nordisk Inc | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Lilly USA, LLC | 2 | $45 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: OTEZLA, VRAYLAR, NURTEC ODT, JARDIANCE, Wegovy, FARXIGA, UBRELVY, Rybelsus.
Industry payments across MD — which companies pay providers there.
